Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.04
Stephens & Co. Reiterates Equal-Weight on The Marzetti, Maintains $135 Price Target
Benzinga
2026.11.04
Rosenblatt Maintains Buy on Booking Holdings, Lowers Price Target to $210
Benzinga
2026.11.04
Keefe, Bruyette & Woods Maintains Outperform on Fiserv, Raises Price Target to $70
Benzinga
2026.11.04
Rosenblatt Maintains Buy on Shopify, Lowers Price Target to $180
Benzinga
2026.11.04
What's Going On With Alibaba Stock Wednesday?
Benzinga
2026.11.04
Keefe, Bruyette & Woods Maintains Outperform on Evertec, Raises Price Target to $42
Benzinga
2026.11.04
TotalEnergies Targets China's Growing Gas Market With 15-Year LNG Agreement
Benzinga
2026.11.04
Performance Food Group Stock Rises After Q1 Earnings Beat, Full-Year Outlook Held
Benzinga
2026.11.04
Neuronetics Q3 EPS $(0.02) Beats $(0.09) Estimate, Sales $41.962M Beat $40.425M Estimate
Benzinga
2026.11.04
Bitcoin Rallies 2%: Could Tightening Supply Spark a Bigger Rally?
Benzinga
2026.11.04
HC Wainwright & Co. Maintains Buy on Mirum Pharmaceuticals, Raises Price Target to $202
Benzinga
2026.11.04
Lifecore Biomedical Q3 EPS $(1.08) Misses $(0.28) Estimate, Sales $25.322M Miss $26.699M Estimate
Benzinga
2026.11.04
HC Wainwright & Co. Assumes Insmed at Buy, Announces Price Target of $220
Benzinga
2026.11.04
Navitas Semiconductor CEO Sees AI Infrastructure Business Tripling in 2027
Benzinga
2026.11.04
Wall Street's Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields
Benzinga
2026.11.04
Bitcoin Fear Spikes on Democrat Sweep but $79,000 Could Flip the Script
Benzinga
2026.11.04
Cushman & Wakefield Affirms FY2026 Adj EPS Guidance of $1.44-$1.50 vs $1.46 Est; Affirms FY2026 Sales Guidance of $11.008B-$11.111B vs $11.172B Est
Benzinga
2026.11.04
Cantor Fitzgerald Reiterates Overweight on BETA Technologies, Maintains $31 Price Target
Benzinga
2026.11.04
Array Technologies Q3 Adj. EPS $0.06 Misses $0.09 Estimate, Sales $330.212M Beat $322.724M Estimate
Benzinga
2026.11.04
Cantor Fitzgerald Maintains Neutral on Dynatrace, Lowers Price Target to $50
Benzinga
2026.11.04
Navios Maritime Partners Q3 Adj. EPS $5.66 Beats $4.63 Estimate, Sales $431.964M Beat $375.270M Estimate
Benzinga
2026.11.04
AC Immune Q3 EPS $(0.16) Beats $(0.22) Estimate, Sales $3.994M Beat $1.000M Estimate
Benzinga
2026.11.04
Odyssey Therapeutics Q3 EPS $(1.10) Misses $(1.08) Estimate
Benzinga
2026.11.04
Vishay Intertechnology Sees Q4 Sales $975.000M-$1.005B vs $985.117M Est
Benzinga
2026.11.04
CS Disco Narrows FY2026 Sales Guidance from $172.000M-$179.000M to $176.100M-$178.100M vs $175.700M Est
Benzinga
2026.11.04
Vishay Intertechnology Q3 EPS $0.37 Beats $0.28 Estimate, Sales $978.940M Beat $963.718M Estimate
Benzinga
2026.11.04
Rapport Therapeutics Q3 EPS $(0.84) Beats $(1.19) Estimate
Benzinga
2026.11.04
uniQure Q3 EPS $(0.88) Beats $(0.92) Estimate, Sales $5.200M Miss $6.178M Estimate
Benzinga
2026.11.04
CS Disco Sees Q4 Sales $45.800M-$47.800M vs $45.875M Est
Benzinga
2026.11.04
Insulet FY2026 Adj EPS expected to be more than $6.46 vs $6.46 Est; Raises FY2026 Sales Guidance from $3.250B-$3.304B to $3.277B-$3.304B vs $3.289B Est
Benzinga
1
...
275
276
277
278
279
280
...
709
>